Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
CytomX Therapeutics Inc
About CTMX
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company is focused on developing conditionally activated, masked biologics designed to be localized to the tumor microenvironment. The Company is developing a pipeline of localized biologics, through its PROBODY therapeutic platform. Its pipeline comprises therapeutic candidates across multiple treatment modalities, including ADCs, T-cell engagers, and immune modulators such as cytokines. Its clinical-stage pipeline includes CX-2051, CX-904 and CX-801. CX-2051 is a masked, conditionally activated ADC directed toward EpCAM, armed with a topoisomerase-1 inhibitor payload. CX-904 is a masked, conditionally activated T-cell-engaging bispecific antibody targeting the EGFR on tumor cells and the CD3 receptor on T cells. CX-801 is a masked interferon alpha-2b PROBODY cytokine with broad potential applicability in traditionally immuno-oncology-sensitive as well as insensitive (cold) tumors.
Find out what a historical investment in CytomX Therapeutics Inc would be worth today using our CTMX stock calculator.
Market Capitalisation
$818.56M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.08M
High today
$3.85
Low today
$3.75
Open price
$3.75
52-week high
$8.21
52-week low
$1.72
Ready to start your investing journey with Stake?
Open an accountHow do I buy CTMX shares in Australia?
Buying CTMX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in CytomX Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CTMX
What is the ticker symbol of CytomX Therapeutics Inc?
The ticker symbol for CytomX Therapeutics Inc is CTMX.
How much is one share of CTMX?
One share of CTMX is valued at $3.80 as of 22 May 2026.
What is the market capitalisation of CytomX Therapeutics Inc CTMX?
As of 22 May 2026 CytomX Therapeutics Inc has a market cap of $818.56M.
What is the 52-week high for CytomX Therapeutics Inc stock?
The CytomX Therapeutics Inc 52-week high stock price is $8.21.
What is the 52-week low for CytomX Therapeutics Inc stock?
The CytomX Therapeutics Inc 52-week low stock price is $1.72.
Can I buy CTMX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CTMX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CTMX on Stake
- Buy CTMX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of CTMX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
CTMX related stocks